Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study
Journal
Vaccine
Journal Volume
40
Journal Issue
45
Date Issued
2022-10-26
Author(s)
Chen, Jau-Yuan
Hwang, Shinn-Jang
Liu, Chiu-Shong
Li, Xiaoling
Fournier, Marion
Yeh, Ting-Yu
Yin, J Kevin
Samson, Sandrine I
Abstract
High-dose influenza vaccine offers better protection against influenza/associated complications compared with standard-dose formulation. We evaluated immunogenicity and safety of high-dose influenza vaccine (QIV-HD) and standard-dose (QIV-SD) in older adults (≥ 65 years) in Taiwan.
Subjects
Clinical study; High dose quadrivalent influenza vaccine; Immunogenicity; Older adults; Safety; Taiwan
SDGs
Type
journal article